Embryonic Stem Cells Market Insights
The global embryonic stem cells market is estimated to grow at a significant CAGR during the forecast period. The key driver for growth in the embryonic stem cells market is increasing government funding for the development of regenerative medicines in most developed countries. Growing applications of embryonic stem cells in the organ transplantation, tissue engineering, and various other applications are further expected to propel the embryonic stem cells market. Rising demand for regenerative medicine is also propelling the growth of the embryonic stem cells market. Increasing R&D activities, investments and research initiatives across the globe by key manufactures of stem cell are some of the major factors expected to propel the market during the forecast period. Increasing support from government and private institutions, along with increasing prevalence of genetic disorders are driving the human embryonic stem cells market. However, Expensive procedures and regulatory complications are some of the major factors expect expected to hinder the growth of embryonic stem cells market.
Embryonic Stem Cells Market: Application Insight
On the basis of application, the embryonic stem cells market is classified into regenerative medicine, stem cell biology research, tissue engineering, and toxicology testing. Regenerative medicine is a branch which deals with tissue engineering and molecular biology. Regenerative medicine is engineering and life science principles to promote regeneration can potentially restore diseased and injured tissues and whole organs. Regenerative medicine can heal or replace tissues and organs damaged by age, disease, or trauma, as well as to normalize congenital defects. Rising prevalence of chronic diseases and genetic disorders, along with growing government investments in regenerative medicine research are some of the major factors expected to propel the market for regenerative medicine segment. Growing number of regenerative medicine companies across the globe is expected to positively impact the market for regenerative medicine segment.
Stem cell biology and research includes all aspects of stem cells and cell biology, regenerative medicine, genetics, developmental biology, molecular biology, and epigenetics. Many of the Institutes and Centers of the Intramural Research Program (IRP) adopted stem cell research program, including the National Heart, Lung and Blood Institute (NHLBI), National Institute of Dental Craniofacial Research (NIDCR), and National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK).
Increasing cases of chronic diseases, trauma injuries, and road accidents are some of the other factors expected to majorly contribute to the growth in the development of tissue engineering solutions. Tissue engineering procedures are used to replace conventional tissue repair options. The technological advancements in 3D tissue engineering, including the use of 3D bio-printers to design in-vitro implants and replacement of embryo cells with proliferative stem cells, are expected to drive the market growth during the forecast period.
Embryonic Stem Cells Market: Regional Insights
North America is expected to dominate the embryonic system cells market. Increasing number of therapeutic research activities in the United States along with increased government funding are some of the major factors expected to drive the market growth in the region. Presence of major market players in the region, strong R&D funding, and growing base of geriatric population are further expected to propel the market growth. Increasing research activities in the field of regenerative medicine, tissue engineering, stem cell biology and growing awareness of personalized medicine are some of the other major factors expected to positively influence the market growth in the North American region. The Asia Pacific region is also expected to record significant growth in the embryonic stem cells market.
Embryonic Stem Cells Market: Vendor Landscape
This report contains a chapter dedicated, to vendors operating in the market, report covering raw material manufactures, equipment developers, manufacturers, and distributors. The report provides insights on a regional level vendors and manufactures. This section of the report entails contact details, experience, products manufactured/supplied, and geographical presence of companies.
Embryonic Stem Cells Market: End-Use Landscape
The end-user landscape entails a list of current and prospective consumers prevailing across the regions. This section briefs you about company addresses, contact details, products, and regional presence of companies who are purchasing or are likely to purchase. The key end-users of the market are CellGenix GmbH, PromoCell GmbH, Kite Pharma and Angel Biotechnology among others.
Embryonic Stem Cells Market Key Players:
Key players in the market include Australian Stem Cell Centre, BD Biosciences, Cellartis AB, Geron Corporation Invitrogen Corporation, Millipore Corporation, SA Biosciences Corporation, Tataa Biocenter, Thermo Scientific, Viacyte, Vitrolife AB, and Advanced Cell Technology Inc among others.
In December 2017: Viacyte Inc. was approved a grant by the California Institute for Regenerative Medicine (CIRM), for the initial development of immune-evasive pluripotent stem cell lines
In 2018, Novartis received EU approval for its CAR-T cell therapy, Kymriah
Avail customized purchase options to meet your exact research needs: